Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | IRMD | CNMD |
|---|---|---|
| Price | $85.47 | $44.23 |
| Change today | ▲ 0.77% | ▼ 0.56% |
| Market cap | $1.09B | $1.32B |
| Return, 3 months | -12.6% | +20.6% |
| Return, year to date | -11.6% | +8.9% |
| Return, 1 year | +12.7% | -4.9% |
| P/E (TTM) | 47.7 | 23.9 |
| P/B | 10.7 | 1.3 |
| P/E percentile vs own 5y | 72nd | 55th |
| Dividend yield | 0.87% | 0.45% |
| Revenue growth (YoY, latest qtr) | +0.3% | +0.3% |
| Net profit growth (YoY) | -9.6% | +7.7% |
| Gross margin | 75.9% | 55.8% |
| Operating margin | 31.9% | 8.0% |
| Net margin | 26.7% | 4.1% |
| Return on equity | 23.5% | 5.5% |
| Analyst target vs. price | +40.4% | +2.3% |
| Analyst buy share | 50% | 0% |
| RSI (14) | 49 | 39 |
| 30-day volatility | 22.0% | 30.7% |
| Max drawdown, 1 year | -21.8% | -34.2% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
